Evaluation of bone marrow aspirates in patients with acute myeloid leukemia at day 14 of induction therapy

BACKGROUND: Early assessment of response to chemotherapy in acute myeloid leukemia may be performed by examining bone marrow aspirate (BMA) or biopsy (BMB); a hypocellular bone marrow sample indicates adequate anti-leukemic activity. We sought to evaluate the quantitative and qualitative assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Souto Filho, João Tadeu D, Loureiro, Monique M, Pulcheri, Wolmar, Morais, José Carlos, Nucci, Marcio, Portugal, Rodrigo D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513973/
https://www.ncbi.nlm.nih.gov/pubmed/26205005
http://dx.doi.org/10.1186/s13000-015-0365-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513973/
https://www.ncbi.nlm.nih.gov/pubmed/26205005
http://dx.doi.org/10.1186/s13000-015-0365-2

Ejemplares similares